University Research Park

Stemina Biomarker Discovery, based in Madison, WI, specializes in developing human in vitro systems for toxicity screening of drug candidates, chemical compounds, and cosmetic and tobacco ingredients. Their innovative assays, such as devTOX quickPredictTM and Cardio quickPredictTM, provide highly predictive data on human responses, serving as effective alternatives to traditional animal testing. In addition to their commitment to toxicology, Stemina is also associated with NeuroPointDX, focusing on the diagnosis and treatment of neurological disorders like autism. By leveraging a shared metabolomics platform, both divisions aim to improve human health through cutting-edge research and comprehensive safety assessment solutions. Generated from the website